Lilly Closes Its Singapore Drug Discovery Center; Is China Discovery Unit In The Works?

The decision is part of a broader corporate R&D restructuring plan, and Lilly will continue some of its priority projects at its Indianapolis headquarters.

More from China

More from Asia